Parties In COVID-Related Hydroxychloroquine Sales Row At Impasse After Mediation
TRENTON, N.J. — In a lawsuit brought by a pharmaceutical supplier alleging that a pharmaceutical manufacturer breached a contract for the purchase of large quantities of hydroxychloroquine and chloroquine phosphate for...To view the full article, register now.
Already a subscriber? Click here to view full article